IPAB

(redirected from Intellectual Property Appellate Board)
AcronymDefinition
IPABInstituto para la Proteccion al Ahorro Bancario (Mexico)
IPABIndependent Payment Advisory Board (healthcare)
IPABIntellectual Property Appellate Board (India)
IPABInstitute of Perception, Action and Behaviour (est. 1998; School of Informatics; University of Edinburgh; Edinburgh, Scotland, UK)
IPABInvasion Plasmid Antigen B
IPABInternational Program for Antarctic Buoys
IPABInternal Pulmonary Artery Banding (cardiothoracic surgery)
References in periodicals archive ?
Basha, Former Judge of Madras High Court and Former Chairman, Intellectual Property Appellate Board, was the Guest of Honour.
A few mergers like that of the Copyright Board with the Intellectual Property Appellate Board seem to be justifiable.
32) Bayer appealed the grant of the compulsory license to the Intellectual Property Appellate Board ("IPAB") who upheld the order, but raised the royalty rate to 7 percent.
Nevertheless, India's Intellectual Property Appellate Board (IPAB) maintained a patent granted on the original compound of the drug called lapatinib.
The Intellectual Property Appellate Board ( IPAB) in Chennai last week upheld a 2011 order of the Controller of Patents to reject the company's patent application for " a method of producing a transgenic plant with increased heat tolerance, salt tolerance, or drug tolerance.
In 2006 the Indian Patent Office denied a patent to Novartis, a decision upheld by the Indian Intellectual Property Appellate Board.
Chennai-based Intellectual Property Appellate Board, which had
The Intellectual Property Appellate Board rejected the German drug maker's appeal of the 2012 ruling on Monday.
The March order of the Controller General of Patents, Designs and Trade Marks, was challenged by Bayer Corp, the north American subsidiary of German company Bayer AG, of compulsorily licensing Natco Pharma to market the generic version of Nexavar (sorafenib tosylate) at the Intellectual Property Appellate Board (IPAB).
Examples of this effect are the recent decisions of the Intellectual Property Appellate Board in Novartis and the Chennai Patent Office in Roche that invalidated patents on pharmaceutical compounds.
Despite this, the Government proposed the creation of the National Company Law Tribunal (NCLT) and the National Tax Tribunal (NTT) in 2002, and the Intellectual Property Appellate Board (IPAB) in 2003.
There are enough examples in India where Indian courts, Intellectual Property Appellate Board and Indian Patent Office have decided in favour of MNCs and against Indian companies in cases related to 3(d) and Compulsory Licensing.
Full browser ?